| Cardiología |
|
| Ronco C;Haapio M;House AA;Anavekar N;Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008 Nov 4;52(19):1527-39 |
|
| Usmanov−Rustam−I, Zueva−Elena−B, Silverberg−Donald−S, Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. Journal of Nephrology, {J−Nephrol}, March/April 2008, vol. 21, no. 2, p. |
|
| Diskin CJ. Erythropoietin, haemoglobin, heart failure, and mortality. Eur Heart J 2008 Sep 11; [Epub ahead of print] |
|
| Handelman GJ, Levin NW. Iron and anemia in human biology-- a review of mechanisms. Heart Fail Rev 2008 Dec;13(4):393-404 |
|
| Murphy CL, McMurray JJ. Approaches to the treatment of anaemia in patients with chronic heart failure. Heart Fail Rev. 2008 Dec;13(4):431-8 |
|
Silverberg DS, Wexler D, Blum M, et Al.
The Use of Subcutaneous Erythropoietin and Intravenous Iron for the Treatment of the Anemia of Severe, Resistant Congestive Heart Failure Improves Cardiac and Renal Function and Functional Cardiac Class, and Markedly Reduces Hospitalizations
(J Am Coll Cardiol 2000;35:1737– 44) 2000 |
|
Silverberg DS, Wexler D, Sheps D, et Al.
The Effect of Correction of Mild Anemia in Severe, Resistant Congestive Heart Failure Using Subcutaneous Erythropoietin and Intravenous Iron: A Randomized Controlled Study
(J Am Coll Cardiol 2001;37:1775– 80) 2001 |
|
Kalra PR, Collier T, Cowie MR, et Al.
Haemoglobin concentration and prognosis in new cases of heart failure
(THE LANCET • Vol 362 • July 19, 2003) 2003 |
|
Silverberg DS, Wexler D, Blum M, et Al.
The cardio-renal anaemia syndrome: does it exist?
(Nephrol Dial Transplant (2003) 18 [Suppl 8*: viii7-viii12) 2003 |
|
O’Meara E, Clayton T, McEntegart MB, et Al.
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program (Circulation. 2006;113: 986-994.) 2006 |
|
Go AS, Yang J, Ackerson LM, et Al.
Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study
(Circulation. 2006;113:2713-2723.) 2006 |
|
Bolger AP, Bartlett FR, et Al.
Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart Failure
(J Am Coll Cardiol 2006-1225) 2006 |
|
Nanas JN, Matsouka C, Karageorgopoulos D, et Al.
Etiology of Anemia in Patients With Advanced Heart Failure
(J Am Coll Cardiol 2006-2485) 2006 |
|
Dec GW
Anemia in Heart Failure Time to Rethink Its Etiology and Treatment?
(J Am Coll Cardiol 2006 2490) 2006 |
|
Beck-Da-Silva L, Rohde LE, Pereira-Barreto AC, et Al.
Rationale and Design of the IRON-HF Study: A Randomized Trial to Assess the Effects of Iron Supplementation in Heart Failure Patients With Anemia
(J Cardiac Fail 2007;13:14e17) 2007 |
|
Toblli et al.
Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency
(JACC Vol. 50, No. 17) 2007 |
|
Christian Mueller, MD, FESC
B-Type Natriuretic Peptides and the General Practitioner
(JACC Vol. 50, No. 17) 2007 |
|
|
|
| Cirugía |
|
Izuel-Rami M, Cuenca J, Garcia JA, et Al.
Efectividad de distintas pautas de tratamiento de la anemia perioperatoria en pacientes ancianos con fractura de cadera
(M. Izuel-Rami et al . Farm Hasp 2005 : 29 :250-257) 2005 |
|
Bisbe E, Rodriguez C, Ruiz A, et Al.
Uso preoperatorio de hierro endovenoso . Una nueva terapeutica en medicina transfusional
(Rev . Esp . Anestesiol . Reanim. 2005 ; 52 : 536-540) 2005 |
|
Piagnerelli M, Rapotec A, Cotton F, et Al.
Iron Administration in the Critically Ill (Semin Hematol 43(suppl 6):S23-S27 © 2006) 2006 |
|
García-Erce J, Cuenca J, Muñoz M
Role of Intravenous Iron in Elective and Non-elective Orthopedic Surgery
(Semin Hematol 43(suppl 6):S32-S35 © 2006) 2006 |
|
Muñoz M, Campos A, García-Erce J
Intravenous Iron in Colorectal Cancer Surgery
(Semin Hematol 43(suppl 6):S36-S38 © 2006) 2006 |
|
Muñoz M, Leal-Noval R, García-Erce J
Intravenous Iron in Cardiac Surgery
(Semin Hematol 43(suppl 6):S39-S42 © 2006) 2006 |
|
Muñoz M, Naveira E, Seara J, et Al.
Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study
(Blackwell Publishing Ltd, Transfusion Medicine, 16, 137–142) 2006 |
|
|
|
| Ginecología y Obstetricia |
|
| Ayub−Rukhsana, Tariq−Nabia, Adil−Malik−Muhammad. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. Journal of the College of Physicians and Surgeons−−Pakistan :Jul 2008, vol. 18, no. 7, p. 424−7, ISSN: 1022−386X. |
|
| Seid MH, Derman RJ, Baker JB. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomised controlled clinical trial. Am J Obstet Gynecol. 2008 Oct;199(4):435.e1-7 |
|
Riaño J, Sánchez L
Manejo de la anemia ferropénica en ginecología y obstetricia con hierro parenteral
(Rev del AWGLA Vol. 1 - No. 2 págs 9-14) 2005 |
|
Canaval H
Abordaje de la anemia ferropénica en la práctica ginecobstétrica
(Rev del AWGLA Vol. 1 - No. 1 págs 18-23) 2005 |
|
Ortiz R
Estudio controlado, aleatorizado, para comparar la efectividad y los efectos colaterales de dos diferentes preparaciones endovenosas de hierro sacarato en pacientes con anemia por deficiencia de hierro
(Rev del AWGLA Vol. 3 - No. 1 págs 50-64) 2007 |
|
Baker W
Iron Deficiency in Pregnancy, Obstetrics, and Gynecology
(HEMATOLOGIC PROBLEMS IN OBSTETRICS, PREGNANCY, AND GYNECOLOGY VOLUME 14 • NUMBER 5 . OCTOBER 2000) 2000 |
|
Perewusnyk G, Huch R, Breymann C
Parenteral iron therapy in obstetrics: 8 years experience with iron–sucrose complex
(British Journal of Nutrition (2002), 88, 3–10) 2002 |
|
Kepczyk T, Cremins J, Long B et Al.
A Prospective, Multidisciplinary Evaluation of Premenopausal Women With Iron-Deficiency Anemia
(Am J Gastroenterol 1999;94:109-115. © 1999 by Am. Coll. of Gastroenterology) 1999 |
|
Rock W, Meeks R
Managing Anemia and Blood Loss in Elective Gynecologic Surgery Patients
(J Reprod Med 2001;46:507-514) 2001) |
|
Larso B, Bremme K, Clyne N, et Al.
Preoperative treatment of anemic women with epoetin beta
(Acta Obstec Gynecol Scand 2001; 80: 559-562) 2001 |
|
Bhandal N, Russell R
Intravenous versus oral iron therapy for postpartum anaemia
(RCOG 2006 BJOG An International Journal of Obstetrics and Gynaecology 2006; 1248-1252) 2006 |
|
Singh K, Fong Y, Kuperan P
A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency in anaemia in pregnancy
(Eu J Haematol 1998; 60: 119-124)) 1998 |
|
Cavill I, Breymann C, Gay C
Iron supplementation in pregnancy and the postpartum
2005 |
|
Rouse D, MacPherson C, Landon M, et Al.
Blood Transfusion and Cesarean Delivery
(Obstet Gynecol 2006-891; 891-897) 2006 |
|
Gredilla E, Gimeno M, Canser E, et Al.
Tratamiento de la anemia en el postparto y en el postoperatorio inmediato de cirugía ginecológica, con hierro intravenoso
(Rev. Esp. Anestesiol. Reanim. 2006; 53: 208-213) 2006 |
|
Breymann C
The Use of Iron Sucrose Complex for Anemia in Pregnancy and the Postpartum Period
(Semin Hematol 43(suppl 6):S28-S31) 2006 |
|
|
|
| Hemato-oncología |
|
| George R Bailie Breaking New Ground in Intravenous Iron Therapy. EUROPEAN HAEMATOLOGY 2008, p. 58−60 |
PDF |
| Krzakowski−M. Epoetin Delta: Efficacy in the Treatment of Anaemia in Cancer Patients Receiving Chemotherapy. Clinical Oncology November 2008, vol. 20, no. 9, p. 705−713 |
|
Doherty−Edmund, Pappadakis−Jennifer, Auerbach−Michael. Intravenous low molecular weight (LMW) iron Dextran (INFeD (R)) results in decreased blood transfusions and substantial cost savings in patients receiving erythropoiesis stimulating agents (ESAs) for chemotherapy induced anemia. TRANSFUSION, 2008, V48, N9, SEP, p 2043. ISSN: 0041−1132. |
|
| Julia Bohlius. Is intravenous iron supplementation with erythropoiesis-stimulating agents beneficial in cancer patients with anemia? Nat Clin Pract Oncol 21 Oct 2008. |
|
| J E F Fitzgerald, J A D Simpson, and A G Acheson. The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer. Br J Haematol 15 Oct 2008. |
|
| Pedrazzoli-Paolo, Farris-Antonio, Del-Prete-Salvatore. Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa. Journal of Clinical Oncology, {J-Clin-Oncol}, 2008, vol. 26, no. 10, p. 1619-1625 |
|
Penninx B, Guralnik J, Onder G, et Al.
Anemia and Decline in Physical Performance among Older Persons
(Am J Med . 2003;115 :104-I10) 2003 |
|
Yee J, Besarab A
Iron Sucrose: The Oldest Iron Therapy Becomes New
(Am J Kidney Dis 40 :1111-1121) 2002 |
|
Abello V, Solano M, Ramírez C, et Al.
Hierro sacarato endovenoso para el tratamiento de la anemia ferropenica en adultos intolerantes al hierro oral
(Acts Med Colomb 2004 ; 29 : 322-327) 2004 |
|
Penninx B, Pluijm S, Lips P, et Al.
Late-Life Anemia Is Associated with Increased Risk of Recurrent Falls
(J Am Geriatr Soc 53:2106–2111, 2005.) 2005 |
|
Gheorghita E, Vulcan G, Mocanu C. et Al.
Venofer - alternativa terapeutica eficienta si sigura a transfuziei de sange in anemia feripriva moderata si severa
(Doc Haematologica Vol. XVI Nr, 1-2 Anul 2006; 28-28) 2006 |
|
James M, Chen Ch, Goddard W, et A.
Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia
(Eu J of Gastroenterology & Hepatology 2005, Vol 17 No 11; 1197-1203) 2005 |
|
Auerbach M, Ballard H, Trout J, et Al.
Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial
(J Clin Oncol 22:1301-1307) 2004 |
|
David H
The Rol of Intravenous Iron in Cancer-Related Anemia (Oncology Vol. 20 No. 8 Sup; 21-24) 2006 |
|
Delfini R, Buzian S, Gomes T, et Al.
O uso intravenoso de sacarato de Hidróxido de Ferro III en pacientes com Anemia Ferropriva
(Rev Assoc Med Bras 2005; 51(6): 323-8) 2005 |
|
Beris P, Maniatis A
Role of Intravenous Iron Therapy in Anemia Management: State of the Art
(Semin Hematol ;s1-s2) 2006 |
|
Heinz L
Iron Metabolism and Iron Supplementation in Anemia of Cancer
(Semin Hematol 43(suppl 6):S13-S17) 2006 |
|
|
|
| Nefrología |
|
| Raimundo M. et al Parenteral iron safety
in haemodialysis patients. Port J Nephrol Hypert 2009; 23(2): 153-159 |
PDF |
| Haddad A. et al Use of Iron Sucrose in Dialysis Patients Sensitive to Iron Dextran. Saudi J Kidney Dis Transpl 2009;20(2):208-211 |
PDF |
| Littlewood TJ Normalization of Hemoglobin in Patients With CKD May Cause Harm: But What Is the Mechanism? Am J Kid Dis Am J Kidney Dis 2008 Oct;52(4):642-4 |
|
| Streja E. et al Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 52:727-73 |
|
| Li−Han, Wang−Shi−xiang. Intravenous Iron Sucrose in Chinese Hemodialysis Patients with Renal Anemia. Blood Purification, {Blood−Purif}, VOL: 26 (2), P: 151−156, ISSN: 0253−5068. |
|
| Vaziri ND;Zhou XJ. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. Nephrol Dial Transplant 2008 Nov 5; [Epub ahead of print] - do not have this paper yet |
|
| JE Novak and LA Szczech Triumph and tragedy: anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens 1 Nov 2008 17(6): p. 580. |
|
| Adeera Levin, MD, Brenda Hemmelgarn, MD PhD, Bruce Culleton, for the Canadian Society of Nephrology. Guidelines for the management of chronic kidney disease Can. Med. Assoc. J. 2008; 179(11): p. 1154-1162. |
|
| Bowe D. IV iron therapy and anemia management in patients on hemodialysis: benefits of a revised CQI strategy. Neprhology Nursing Journal. 2008: 35 (4) 371-7Auerbach-M, Al-Talib-K. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Kidney International, VOL: 73 (5), P: 528-530 |
|
| Bradley A Ford, Daniel W Coyne, Charles S Eby, and Mitchell G Scott. Variability of ferritin measurements in chronic kidney disease; implications for iron management. Kidney Int 8 Oct 2008 |
|
| Rozen-Zvi. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review and Meta-analysis. Am J Kid Dis 2008; 52 (5) 879-906 |
|
Wagner P
Anemia de la Enfermedad Renal Crónica (ERC)
(Revista del AWGLA, jun 2003; 10-19) 2006 |
|
Abensur H, Gomes M, Bregman R, et Al.
Rol de la deficiencia de Hierro en la Anemia de la Enfermedad Renal Crónica (Revista del AWG, Vol1 N1;14-23) 2005 |
|
Fishbane S, Fre G, Maesaka J
Reduction in Recombinant Human Erythropoietin Doses by the Use of Chronic Intravenous Iron Supplementation
(American Journal of Kidney Diseases, Vol 26, No 1 (July), 1995 : pp 41-46) 1995 |
|
Pos J, Wilkes B, Michelis M
Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin
(International Urology and Nephrology (2006) 38:719–723) 2006 |
|
Macdougall I, Schaefer R, Silverberg D, et Al.
Educational Statement on the Iron Management of Anemia
(ITO) 2004 |
|
Macdougall I, Khasabov N, Lameire N, et Al.
Anemia Management in CKD (predyalisis)Patients
(ITO) 2005 |
|
Blaustein D, Schwenk M, Chattopadhayay J, et Al.
Recent experience with high-dose intravenous Iron administration
(Kidney Int 2006-s26) 2006 |
|
Phrommintikul A, Haas S, Elsik M, et Al.
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
(Lancet 2007; 369: 381–88) 2007 |
|
Drüeke T, Locatelli F, Clyne N, et Al.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
(N Engl J Med 2006;355:2071-84.) 2006 |
|
Macdougall I
Experience With Intravenous Iron in Nephrology
(Semin Hematol 43(suppl 6):S9-S12) 2006 |
|
|
|
| Pediatría |
|
Madero D
Eficacia y seguridad del complejo de HIDRÓXIDO DE HIERRO FÉRRICO (III) y Polimaltoa (IPC) vs el Hierro aminoquelado en el manejo de la anemia ferropénica en niños
(Revista del AWGLA, enero 2007; 28-39) 2007 |
|
Núñez O, Del Águila C
Estudio controlado de dos compuestos de POLIMALTOSADO FÉRRICO en el tratamiento de Anemia ferropénica en noños de 6 meses a 2 años
(Revista del AWGLA, Vol.1 Nº2; 31-38) 2005 |
|
Del Águila C, Núñez O
Estudio controlado de POLIMALTOSADO FÉRRICO (MALTOFER®) vs SULFATO FERROSO (FERINSOL®) en el tratamiento de anemia ferropénica en niños de 6 meses a 2 años
(Revista del AWGLA, Vol1 Nº1; 33-42) 2005 |
|
Ramírez F, Planchet J, Galarraga D, et Al.
Anemia ferropénica en niños. Rapidez de la respuesta al tratamiento con POLIMALTOSADO FÉRRICO (IPC) y FERRITINA (F o proteína férrica)
(Revista del AWGLA, jun 2006; 35-43) 2006 |
|
Galarraga T, Zacarías I, Yañez C, et Al.
Comparación del complejo de HIERRO-POLIMALTOSA con SULFATO FERROSO en términos de tolerancia y aceptabilidad en lactantes: un estudio abierto, cruzado y aleatorizado
(Revista del AWGLA, Vol.1 Nº1; 43-53) 2005 |
|
Jacobs P, Wood L, Bird A
Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia (Hematology, 2000, Vol. 5, pp. 77-83) 2000 |
|
Yage J, Hartfiel D
Neurologic Manifestations of Iron Deficiency in Childhood
(Pediatr Neurol 2002 ;27 :85-92) 2002 |
|
Irwin J, Kirchner J
Anemia in Children
(Am Fam Physiciam Vol.64 Nº8; 1379-1386) 2001 |
|
Walter T, Zacarías I, Yañez C
Tolerance and acceptability in infants of Iron Polymaltose Complex
(Ars Medici no.9 2005 ::428-431) 2005 |
|
|
|
| Otros |
|
Shamah-Levy, T et al. Ferrous Gluconate and Ferrous Sulfate Added to a Complementary Food Distributed by the Mexican Nutrition Program Oportunidades Have a Comparable Efficacy to Reduce Iron Deficiency in Toddlers. J Pediatr Gastroenterol Nutr. 2008: 47(5): 660-666. |
|
| Haskell CF et al., Cognitive and mood effects in healthy children during 12 weeks' supplementation with multi-vitamin/minerals. Br J Nutr 2008; 100 (5): 1086-96 |
|
Baron−Joel, Ben−David−Gila, Hallak−Mordechai. Changes in non−transferrin−bound iron (NTBI) in pregnant women on iron supplements. Eur J Obstet Gynecol Reprod Biol, 2008: 140 (2), 281−282 |
|
| Stein−Jürgen. Therapy for iron deficiency anemia in patients with chronic inflammatory bowel diseases (CIBD). Journal fur Pharmakologie und Therapie, {J−Pharmakol−Ther}, May 2008, vol. 17, no. 2, p. 42−44, 3 refs (German only) |
|
| S Lasocki, M Garnier, L Ley, A Benbarra, C Beaumont, and P Montravers. [How is iron prescribed in French ICUs: A practice survey.] Ann Fr Anesth Reanim 24 Oct 2008. - article in French, abstract only |
|
| Asare K. Anemia of critical illness. Pharmacotherapy 2008 Oct;28(10):1267-82 |
|
| Clauder Trenkwalder, Wayne A Hening, Pasquale Montagna, Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice. Mov Disord 16 Oct 2008 |
|
| Adrian Covic, Jorge Cannata-Andia, Giovanni Cancarini et al Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council Nephrol. Dial. Transplant. published October 2008, 10.1093/ndt/gfn519 |
|
Erichsen K, Ulvik R, Grimstad T, et Al
Effects of ferrous sulphate and non-ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease
(Aliment Pharmacol Ther 2005; 22: 831–838) 2005 |
|
Ganz T, Nemeth E
Iron imports. IV. Hepcidin and regulation of body iron metabolism
(Am J Physiol Gastrointest Liver Physiol 290: G199–G203, 2006; doi:10.1152/ajpgi.00412.2005) 2005 |
|
Fisher A, Naughton D
Iron supplements: the quick fix with long-term consequences
(Nutrition Journal 2004, 3:2) 2004 |
|
|
|
| Novedades |
|
|
|
| Cardiología |
|
| - Ronco C;Haapio M;House AA;Anavekar N;Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008 Nov 4;52(19):1527-39 |
|
| - Usmanov−Rustam−I, Zueva−Elena−B, Silverberg−Donald−S, Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. Journal of Nephrology, {J−Nephrol}, March/April 2008, vol. 21, no. 2, p. |
|
| - Diskin CJ. Erythropoietin, haemoglobin, heart failure, and mortality. Eur Heart J 2008 Sep 11; [Epub ahead of print] |
|
| - Handelman GJ, Levin NW. Iron and anemia in human biology-- a review of mechanisms. Heart Fail Rev 2008 Dec;13(4):393-404 |
|
| - Murphy CL, McMurray JJ. Approaches to the treatment of anaemia in patients with chronic heart failure. Heart Fail Rev. 2008 Dec;13(4):431-8 |
|
| |
|
| Cirugía |
|
| - Ayub−Rukhsana, Tariq−Nabia, Adil−Malik−Muhammad. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. Journal of the College of Physicians and Surgeons−−Pakistan :Jul 2008, vol. 18, no. 7, p. 424−7, ISSN: 1022−386X. |
|
| - Seid MH, Derman RJ, Baker JB. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomised controlled clinical trial. Am J Obstet Gynecol. 2008 Oct;199(4):435.e1-7. |
|
| |
|
| Hemato-oncología |
|
| George R Bailie Breaking New Ground in Intravenous Iron Therapy. EUROPEAN HAEMATOLOGY 2008, p. 58−60 |
PDF |
| - Krzakowski−M. Epoetin Delta: Efficacy in the Treatment of Anaemia in Cancer Patients Receiving Chemotherapy. Clinical Oncology November 2008, vol. 20, no. 9, p. 705−713 |
|
| - Doherty−Edmund, Pappadakis−Jennifer, Auerbach−Michael. Intravenous low molecular weight (LMW) iron Dextran (INFeD (R)) results in decreased blood transfusions and substantial cost savings in patients receiving erythropoiesis stimulating agents (ESAs) for chemotherapy induced anemia. TRANSFUSION, 2008, V48, N9, SEP, p 2043. ISSN: 0041−1132. |
|
| - Julia Bohlius. Is intravenous iron supplementation with erythropoiesis-stimulating agents beneficial in cancer patients with anemia? Nat Clin Pract Oncol 21 Oct 2008. |
|
| - J E F Fitzgerald, J A D Simpson, and A G Acheson. The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer. Br J Haematol 15 Oct 2008. |
|
| - Pedrazzoli-Paolo, Farris-Antonio, Del-Prete-Salvatore. Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa. Journal of Clinical Oncology, {J-Clin-Oncol}, 2008, vol. 26, no. 10, p. 1619-1625 |
|
| |
|
| Nefrología |
|
| Raimundo M. et al Parenteral iron safety
in haemodialysis patients. Port J Nephrol Hypert 2009; 23(2): 153-159 |
PDF |
| Haddad A. et al Use of Iron Sucrose in Dialysis Patients Sensitive to Iron Dextran. Saudi J Kidney Dis Transpl 2009;20(2):208-211 |
PDF |
| - Littlewood TJ Normalization of Hemoglobin in Patients With CKD May Cause Harm: But What Is the Mechanism? Am J Kid Dis Am J Kidney Dis 2008 Oct;52(4):642-4 |
|
| - Streja E. et al Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 52:727-73 |
|
| - Li−Han, Wang−Shi−xiang. Intravenous Iron Sucrose in Chinese Hemodialysis Patients with Renal Anemia. Blood Purification, {Blood−Purif}, VOL: 26 (2), P: 151−156, ISSN: 0253−5068. |
|
| - Vaziri ND;Zhou XJ. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. Nephrol Dial Transplant 2008 Nov 5; [Epub ahead of print] - do not have this paper yet |
|
| - JE Novak and LA Szczech Triumph and tragedy: anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens 1 Nov 2008 17(6): p. 580. |
|
| - Adeera Levin, MD, Brenda Hemmelgarn, MD PhD, Bruce Culleton, for the Canadian Society of Nephrology. Guidelines for the management of chronic kidney disease Can. Med. Assoc. J. 2008; 179(11): p. 1154-1162. |
|
| - Bowe D. IV iron therapy and anemia management in patients on hemodialysis: benefits of a revised CQI strategy. Neprhology Nursing Journal. 2008: 35 (4) 371-7 |
|
| - Auerbach-M, Al-Talib-K. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Kidney International, VOL: 73 (5), P: 528-530 |
|
| - Bradley A Ford, Daniel W Coyne, Charles S Eby, and Mitchell G Scott. Variability of ferritin measurements in chronic kidney disease; implications for iron management. Kidney Int 8 Oct 2008 |
|
| - Rozen-Zvi. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review and Meta-analysis. Am J Kid Dis 2008; 52 (5) 879-906 |
|
| |
|
| Pediatría |
|
| |
|
| |
|
| Otros |
|
| - Shamah-Levy, T et al. Ferrous Gluconate and Ferrous Sulfate Added to a Complementary Food Distributed by the Mexican Nutrition Program Oportunidades Have a Comparable Efficacy to Reduce Iron Deficiency in Toddlers. J Pediatr Gastroenterol Nutr. 2008: 47(5): 660-666. |
|
| - Haskell CF et al., Cognitive and mood effects in healthy children during 12 weeks' supplementation with multi-vitamin/minerals. Br J Nutr 2008; 100 (5): 1086-96 |
|
| - Baron−Joel, Ben−David−Gila, Hallak−Mordechai. Changes in non−transferrin−bound iron (NTBI) in pregnant women on iron supplements. Eur J Obstet Gynecol Reprod Biol, 2008: 140 (2), 281−282 |
|
| - Stein−Jürgen.. Therapy for iron deficiency anemia in patients with chronic inflammatory bowel diseases (CIBD). Journal fur Pharmakologie und Therapie, {J−Pharmakol−Ther}, May 2008, vol. 17, no. 2, p. 42−44, 3 refs (German only) |
|
| - S Lasocki, M Garnier, L Ley, A Benbarra, C Beaumont, and P Montravers. [How is iron prescribed in French ICUs: A practice survey.] Ann Fr Anesth Reanim 24 Oct 2008. - article in French, abstract only |
|
| - Asare K. Anemia of critical illness. Pharmacotherapy 2008 Oct;28(10):1267-82 |
|
| - Clauder Trenkwalder, Wayne A Hening, Pasquale Montagna, Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice. Mov Disord 16 Oct 2008 |
|
| - Adrian Covic, Jorge Cannata-Andia, Giovanni Cancarini et al Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council Nephrol. Dial. Transplant. published October 2008, 10.1093/ndt/gfn519 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
